DOCSLIB.ORG

Unraveling the Signaling Pathways Promoting Fibrosis in Dupuytrents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Unraveling the Signaling Pathways Promoting Fibrosis in Dupuytrents Unraveling the signaling pathways promoting fibrosis PNAS PLUS in Dupuytren’s disease reveals TNF as a therapeutic target Liaquat S. Verjeea, Jennifer S. N. Verhoekxa,b, James K. K. Chana, Thomas Krausgrubera, Vicky Nicolaidoua, David Izadia, Dominique Davidsonc, Marc Feldmanna,1, Kim S. Midwooda, and Jagdeep Nanchahala,1 aKennedy Institute of Rheumatology, University of Oxford, London W6 8LH, United Kingdom; bDepartment of Plastic and Reconstructive Surgery, Erasmus Medical Centre, 3015, Rotterdam, The Netherlands; and cDepartment of Plastic Surgery, St John’s Hospital, Livingstone EH54 6PP, United Kingdom Contributed by Marc Feldmann, January 18, 2013 (sent for review December 5, 2012) Dupuytren’sdiseaseisaverycommonprogressivefibrosis of the characteristically express α-smooth muscle actin (α-SMA), which palm leading to flexion deformities of the digits that impair hand is the actin isoform typical of vascular smooth muscle cells (6). function. The cell responsible for development of the disease is the Fibroblast to myofibroblast differentiation is characterized by myofibroblast. There is currently no treatment for early disease or for α-SMA expression, and exposure of the cells to stress leads to the preventing recurrence following surgical excision of affected tissue incorporation of α-SMA protein into stress fibers (7). Unlike in in advanced disease. Therefore, we sought to unravel the signaling granulation tissue, where the expression of α-SMA is transient (8), pathways leading to the development of myofibroblasts in Dupuyt- α-SMA expression is persistent in Dupuytren’s disease. The de- ren’s disease. We characterized the cells present in Dupuytren’s tis- velopment of myofibroblasts has been shown to be dependent on sue and found significant numbers of immune cells, including a number of different environmental cues, including tension in the fl classically activated macrophages. High levels of proin ammatory matrix and exposure to a variety of different soluble mediators (7). ’ cytokines were also detected in tissue from Dupuytren s patients. The best studied of these is TGF-β1. The expression of TGF-β1 We compared the effects of these cytokines on contraction and and associated signaling molecules is elevated in Dupuytren’s fi fi pro brotic signaling pathways in broblasts from the palmar and disease (9), and Dupuytren’s myofibroblasts or dermal fibroblasts nonpalmar dermis of Dupuytren’s patients and palmar fibroblasts MEDICAL SCIENCES ’ from the same patients proliferated in response to 1 or 5 ng/mL from non-Dupuytren s patients. Exogenous addition of TNF, but not TGF-β1 (10). Normal human dermal fibroblasts cultured in other cytokines, including IL-6 and IL-1β, promoted differentiation stressed collagen lattices also showed increased α-SMA expres- into specifically of palmar dermal fibroblasts from Dupuytren’s sion when treated with 1 ng/mL TGF-β1 (11). Fibroblasts derived patients in to myofibroblasts. We also demonstrated that TNF acts fi from the transverse carpal ligament of patients unaffected by via the Wnt signaling pathway to drive contraction and pro brotic ’ β signaling in these cells. Finally, we examined the effects of targeted Dupuytren s disease exposed to 2 ng/mL TGF- 1 showed no increase in α-SMA staining (12). However, these fibroblasts, as cytokine inhibition. Neutralizing antibodies to TNF inhibited the ’ fi contractile activity of myofibroblasts derived from Dupuytren’s well as Dupuytren s myo broblasts, did exhibit increased iso- patients, reduced their expression of α-smooth muscle actin, and metric contraction of collagen lattices when exposed to 12.5 ng/ β mediated disassembly of the contractile apparatus. Therefore, we mL of TGF- 1, with higher doses being inhibitory (13). There- β α showed that localized inflammation in Dupuytren’s disease contrib- fore, TGF- 1 can promote cell proliferation and increase -SMA utes to the development and progression of this fibroproliferative expression and matrix contraction in a manner dependent on disorder and identified TNF as a therapeutic target to down-regu- both the dose and the tissue of origin of the cells. late myofibroblast differentiation and activity. Inflammation is also known to play a crucial role in fibrosis, and various proinflammatory cytokines have been implicated in driving musculoskeletal | scarring Significance upuytren’s disease is a common fibroproliferative disorder Dwith a prevalence >7% in the United States (1). The classic Fibrosis, a hallmark of many clinical disorders, occurs because of description of disease progression is the initial appearance of uncontrolled myofibroblast activity. We studied Dupuytren’s palmar nodules characterized by high cellularity and cell pro- disease, a common hereditable fibrotic condition that causes the liferation, followed by the development of cords. This phase is fingers to irreversibly curl toward the palm. We found that followed by a final fibrotic stage that is associated with matura- freshly isolated tissue from Dupuytren’s patients contained tion of the cords and digital contractures resulting in significant macrophages and released proinflammatory protein mediators impairment of hand function (2). Established flexion deformities (cytokines). Of the cytokines, only TNF selectively converted of the digits are most commonly treated by surgical excision normal fibroblasts from the palm of patients with Dupuytren’s (fasciectomy) of the cord. The long recovery time following disease into myofibroblasts via activation of the Wnt signaling surgery has led to description of alternative techniques of dis- pathway. Conversely, blockade of TNF resulted in reversal of the rupting the cord with a needle (percutaneous fasciotomy) (3) or myofibroblast phenotype. Therefore, TNF inhibition may pre- enzymatic digestion using collagenase injections (4). However, vent progression or recurrence of Dupuytren’s disease. even following surgery, patients often have significant residual dysfunction due to irreversible fixed flexion deformities of the Author contributions: M.F., K.S.M., and J.N. designed research; L.S.V., J.S.N.V., J.K.K.C., T.K., fi V.N., and D.I. performed research; D.D. and J.N. collected human tissue samples; L.S.V., J.S.N.V., joints. Currently, there is no speci c treatment for early disease J.K.K.C., T.K., V.N., D.I., D.D., M.F., K.S.M., and J.N. analyzed data; and L.S.V., J.S.N.V., J.K.K.C., or prevention of recurrence following fasciectomy or fasciotomy T.K., V.N., D.I., D.D., M.F., K.S.M., and J.N. wrote the paper. ’ of Dupuytren s cords. Therefore, we sought to unravel the cel- The authors declare no conflict of interest. lular mechanisms leading to the development of this disease to 1To whom correspondence may be addressed. E-mail: [email protected] reveal novel potential therapeutic targets. or [email protected]. The cell responsible for matrix deposition and contraction This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. in Dupuytren’s disease is the myofibroblast (5). Myofibroblasts 1073/pnas.1301100110/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1301100110 PNAS Early Edition | 1of10 Downloaded by guest on September 26, 2021 the progression of fibrotic diseases (14). Histological studies have Results identified the presence of immune cells in Dupuytren’s disease; in Cells in Dupuytren’s Nodules and the Cytokines They Produce. To particular, the number of macrophages was shown to correlate quantify the presence of immune cells in Dupuytren’s tissue, flow fi with the quantity of myo broblasts (15). Intralesional steroid cytometric analysis was performed on cells directly disaggregated fl injections led to temporary softening and attening of Dupuyt- from Dupuytren’s nodules. The majority (87 ± 6%) of cells were ’ ren s nodules (16) and reduced recurrence following percutaneous myofibroblasts, together with a significant number of macro- needle fasciotomy (17). It has been suggested that this therapeutic phages (6.5 ± 2.3%), with the classically activated (CD68+/ fi ’ bene t of steroids in early Dupuytren s disease may be due to CD163−) M1 phenotype predominating (4.8 ± 2.2%; Fig. 1 A and diminished leukocyte recruitment (18), as well as increased apo- B). Immunohistochemistry showed that the macrophages were ptosis of macrophages and fibroblasts, with reduced proliferation distributed throughout the Dupuytren’s nodules (Fig. 1C) and of the latter (19). However, the link between disease progression clustered around the blood vessels. Serial histological sections and localized inflammation in Dupuytren’s tissue remains unclear, revealed no neutrophil elastase positive cells. Soluble cytokines and molecular mechanisms by which inflammatory cytokines di- fi produced by freshly disaggregated Dupuytren’s nodule tissue in- rectly drive myo broblast differentiation remain unknown. β ± ± To explore these issues, we systematically studied the cytokines cluded variable amounts of TGF- 1 (mean SD: 236 248 pg/ – ± ± produced by freshly disaggregated cells from Dupuytren’s nod- mL; range, 4 852 pg/mL), as well as TNF (mean SD: 78 26 pg/ ± ± ules. TNF was identified as a key regulator of the myofibroblast mL), IL-6 (mean SD: 5,591 3,215 pg/mL), and consistent with phenotype, and TNF blockade in vitro led to down-regulation of the presence of substantial numbers of classically activated M1 the myofibroblast phenotype. Our data indicate that progression macrophages, GM-CSF (mean ± SD: 64 ± 24 pg/mL). Low levels of of early palmar nodules of Dupuytren’s disease to deposition of IL-1β (mean ± SD: 17 ± 10 pg/mL), IL-10 (mean ± SD: 11 ± 9pg/ extracellular matrix in cords and subsequent digital contractures mL), and IFNγ (mean ± SD: 7 ± 6 pg/mL) were observed (Fig. 1D). in vivo may be prevented by local administration of a TNF in- Cells from the same patient samples were also maintained in hibitor. This approach may also be effective in preventing re- culture and examined for constituent cells and cytokine profiles currence following surgery, percutaneous needle fasciotomy, or at passage 2. Macrophages were absent, and the passaged cells collagenase treatment.
Load more

Recommended publications
  • Reactive Stroma in Human Prostate Cancer: Induction of Myofibroblast Phenotype and Extracellular Matrix Remodeling1
    2912 Vol. 8, 2912–2923, September 2002 Clinical Cancer Research Reactive Stroma in Human Prostate Cancer: Induction of Myofibroblast Phenotype and Extracellular Matrix Remodeling1 Jennifer A. Tuxhorn, Gustavo E. Ayala, Conclusions: The stromal microenvironment in human Megan J. Smith, Vincent C. Smith, prostate cancer is altered compared with normal stroma and Truong D. Dang, and David R. Rowley2 exhibits features of a wound repair stroma. Reactive stroma is composed of myofibroblasts and fibroblasts stimulated to Departments of Molecular and Cellular Biology [J. A. T., T. D. D., express extracellular matrix components. Reactive stroma D. R. R.] and Pathology [G. E. A., M. J. S., V. C. S.] Baylor College of Medicine, Houston, Texas 77030 appears to be initiated during PIN and evolve with cancer progression to effectively displace the normal fibromuscular stroma. These studies and others suggest that TGF-␤1isa ABSTRACT candidate regulator of reactive stroma during prostate can- Purpose: Generation of a reactive stroma environment cer progression. occurs in many human cancers and is likely to promote tumorigenesis. However, reactive stroma in human prostate INTRODUCTION cancer has not been defined. We examined stromal cell Activation of the host stromal microenvironment is pre- phenotype and expression of extracellular matrix compo- dicted to be a critical step in adenocarcinoma growth and nents in an effort to define the reactive stroma environ- progression (1–5). Several human cancers have been shown to ment and to determine its ontogeny during prostate cancer induce a stromal reaction or desmoplasia as a component of progression. carcinoma progression. However, the specific mechanisms of Experimental Design: Normal prostate, prostatic intra- stromal cell activation are not known, and the extent to which epithelial neoplasia (PIN), and prostate cancer were exam- stroma regulates the biology of tumorigenesis is not fully un- ined by immunohistochemistry.
    [Show full text]
  • Skeletal Reorganization and Chromatin Accessibility During Re- Vascularization-Based Blastema Regeneration
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 23 April 2021 doi:10.20944/preprints202104.0642.v1 Article Keratin5-BMP4 mechanosignaling network regulates cell cyto- skeletal reorganization and chromatin accessibility during re- vascularization-based blastema regeneration Xuelong Wang 1,2,4,†, Huiping Guo 1,6,†, Feifei Yu 1,†, Hui Zhang 1, Ying Peng 1, Chenghui Wang 3, Gang Wei 2, Jizhou Yan 1,5,* 1 Department of Developmental Biology, Institute for Marine Biosystem and Neurosciences, Shanghai Ocean University, Shanghai, China. 2 CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China 3 Department of Aquaculture, Shanghai Ocean University, Shanghai, China. 4 Present address: Pancreatic Disease Center, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong Univer- sity, Shanghai, China. 5 CellGene Bioscience, Shanghai, China. * Correspondence: [email protected] † These authors contributed equally to this study. Abstract: Heart regeneration after myocardial infarction remains challenging in reconstruction of blood resupply system. Here, we find that in zebrafish heart after resection of the ventricular apex, the local myocardial cells and the clotted blood cells undergo cell remodeling process via cytoplas- mic exocytosis and nuclear reorganization within revascularization-based blastema. The regenera- tive processes are visualized by spatiotemporal expression of three blastema representative factors (alpha-SMA- which marks for fibrogenesis, Flk1for angiogenesis/hematopoiesis, and Pax3a for re- musculogensis)，and two histone modifications (H3K9Ac and H3K9Me3 mark for chromatin re- modeling). Using the cultured zebrafish embryonic fibroblasts we identify blastema fraction com- ponents and show that Krt5 peptide could link cytoskeleton network and BMP4 signaling pathway to regulate the transcription and chromatin accessibility at the blastema representative genes and bmp4 genes.
    [Show full text]
  • Evidence for the Nonmuscle Nature of The" Myofibroblast" of Granulation Tissue and Hypertropic Scar. an Immunofluorescence Study
    American Journal of Pathology, Vol. 130, No. 2, February 1988 Copyright i American Association of Pathologists Evidencefor the Nonmuscle Nature ofthe "Myofibroblast" ofGranulation Tissue and Hypertropic Scar An Immunofluorescence Study ROBERT J. EDDY, BSc, JANE A. PETRO, MD, From the Department ofAnatomy, the Department ofSurgery, and JAMES J. TOMASEK, PhD Division ofPlastic and Reconstructive Surgery, and the Department of Orthopaedic Surgery, New York Medical College, Valhalla, New York Contraction is an important phenomenon in wound cell-matrix attachment in smooth muscle and non- repair and hypertrophic scarring. Studies indicate that muscle cells, respectively. Myofibroblasts can be iden- wound contraction involves a specialized cell known as tified by their intense staining of actin bundles with the myofibroblast, which has morphologic character- either anti-actin antibody or NBD-phallacidin. Myofi- istics of both smooth muscle and fibroblastic cells. In broblasts in all tissues stained for nonmuscle but not order to better characterize the myofibroblast, the au- smooth muscle myosin. In addition, nonmuscle myo- thors have examined its cytoskeleton and surrounding sin was localized as intracellular fibrils, which suggests extracellular matrix (ECM) in human burn granula- their similarity to stress fibers in cultured fibroblasts. tion tissue, human hypertrophic scar, and rat granula- The ECM around myofibroblasts stains intensely for tion tissue by indirect immunofluorescence. Primary fibronectin but lacks laminin, which suggests that a antibodies used in this study were directed against 1) true basal lamina is not present. The immunocytoche- smooth muscle myosin and 2) nonmuscle myosin, mical findings suggest that the myofibroblast is a spe- components ofthe cytoskeleton in smooth muscle and cialized nonmuscle type of cell, not a smooth muscle nonmuscle cells, respectively, and 3) laminin and 4) cell.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • Myofibroblasts in Schistosomal Portal Fibrosis Of
    Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 94(1): 87-93, Jan./Feb. 1999 87 Myofibroblasts in Schistosomal Portal Fibrosis of Man + Zilton A Andrade/ , Sylviane Guerret*, André LM Fernandes Centro de Pesquisas Gonçalo Moniz-Fiocruz , Rua Valdemar Falcão 121, 40295-001 Salvador, BA, Brasil *Laboratoire Marcel Merieux, Avenue Tony Garnier, Lyon, France Myofibroblasts, cells with intermediate features between smooth muscle cells and fibroblasts, have been described as an important cellular component of schistosomal portal fibrosis. The origin, distribu- tion and fate of myofibroblasts were investigated by means of light, fluorescent, immunoenzymatic and ultrastructural techniques in wedge liver biopsies from 68 patients with the hepatosplenic form of schistosomiasis. Results demonstrated that the presence of myofibroblasts varied considerably from case to case and was always related to smooth muscle cell dispersion, which occurred around medium- sized damaged portal vein branches. By sequential observation of several cases, it was evident that myofibroblasts derived by differentiation of vascular smooth muscle and gradually tended to disappear, some of them further differentiating into fibroblasts. Thus, in schistosomal pipestem fibrosis myofibroblasts appear as transient cells, focally accumulated around damaged portal vein branches, and do not seem to have by themselves any important participation in the pathogenesis of hepatosplenic schistoso- miasis. Key words: myofibroblast - schistosomiasis - pipestem fibrosis - liver The characteristic
    [Show full text]
  • Development and Characterisation of 3D Skeletal Muscle Constructs Under Defined Mechanical Regulation
    Development and Characterisation of 3D Skeletal Muscle Constructs under Defined Mechanical Regulation By Umber Cheema, B.Sc (Hons) UCL A thesis submitted in partial fulfilment for the Degree of Doctor of Philosophy Royal Free and University College Medical School July 2004 Department of Surgery, Charles Bell House, 64 Riding House Street, London W1W 7EJ. Department of Anatomy and Developmental Biology, Royal Free and University College Medical school, Royal Free Campus, Rowland Hill street, London NW2 2PF 1 UMI Number: U591876 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Dissertation Publishing UMI U591876 Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Acknowledgements I would like to thank my primary supervisor, Robert Brown, for all his help, encouragement, guidance and support over the course of my studies. He has helped make this whole learning experience a truly enjoyable one. I am also deeply thankful for the support of my second supervisor, Geoffrey Goldspink, who has given me a sound understanding of muscle and for giving me the opportunity to study. I would like to thank all the staff and students I have had the privilege of working with.
    [Show full text]
  • Fibroblasts and Myofibroblasts in Wound Healing: Force Generation
    Journal of Tissue Viability (2011) 20, 108e120 www.elsevier.com/locate/jtv Basic research Fibroblasts and myofibroblasts in wound healing: Force generation and measurement Bin Li a, James H.-C. Wang b,* a Orthopedic Institute, Soochow University, 708 Renmin Road, Suzhou, Jiangsu 215007, China b MechanoBiology Laboratory, Departments of Orthopaedic Surgery, Bioengineering, and Mechanical Engineering and Materials Science, University of Pittsburgh, 210 Lothrop St, BST E1640, Pittsburgh, PA 15213, USA KEYWORDS Abstract Fibroblasts are one of the most abundant cell types in connective Fibroblasts; tissues. These cells are responsible for tissue homeostasis under normal physiolog- Myofibroblasts; ical conditions. When tissues are injured, fibroblasts become activated and differ- Wounds; entiate into myofibroblasts, which generate large contractions and actively Contraction; produce extracellular matrix (ECM) proteins to facilitate wound closure. Both fibro- Measurement blasts and myofibroblasts play a critical role in wound healing by generating trac- tion and contractile forces, respectively, to enhance wound contraction. This review focuses on the mechanisms of force generation in fibroblasts and myofibro- blasts and techniques for measuring such cellular forces. Such a topic was chosen specifically because of the dual effects that fibroblasts/myofibroblasts have in wound healing processe a suitable amount of force generation and matrix deposi- tion is beneficial for wound healing; excessive force and matrix production, however, result in tissue scarring and even malfunction of repaired tissues. There- fore, understanding how forces are generated in these cells and knowing exactly how much force they produce may guide the development of optimal protocols for more effective treatment of tissue wounds in clinical settings. ª 2009 Tissue Viability Society.
    [Show full text]
  • Enhanced Upregulation of Smooth Muscle Related Transcripts by Tgfb2 in Asthmatic (Myo) Fibroblasts J Wicks, H M Haitchi, S T Holgate, D E Davies, R M Powell
    313 ASTHMA Thorax: first published as 10.1136/thx.2005.050005 on 31 January 2006. Downloaded from Enhanced upregulation of smooth muscle related transcripts by TGFb2 in asthmatic (myo) fibroblasts J Wicks, H M Haitchi, S T Holgate, D E Davies, R M Powell ............................................................................................................................... Thorax 2006;61:313–319. doi: 10.1136/thx.2005.050005 Background: Transforming growth factor beta (TGFb) upregulates a number of smooth muscle specific genes in (myo)fibroblasts. As asthma is characterised by an increase in airway smooth muscle, we postulated that TGFb2 favours differentiation of asthmatic (myo)fibroblasts towards a smooth muscle phenotype. Methods: Primary fibroblasts were grown from bronchial biopsy specimens from normal (n = 6) and asthmatic (n = 7) donors and treated with TGFb2 to induce myofibroblast differentiation. The most stable genes for normalisation were identified using RT-qPCR and the geNorm software applied to a panel of 12 See end of article for authors’ affiliations ‘‘housekeeping’’ genes. Expression of a-smooth muscle actin (aSMA), heavy chain myosin (HCM), ....................... calponin 1 (CPN 1), desmin, and c-actin were measured by RT-qPCR. Protein expression was assessed by immunocytochemistry and western blotting. Correspondence to: Dr R M Powell, The Brooke Results: Phospholipase A2 and ubiquitin C were identified as the most stably expressed and practically Laboratory, Level F, South useful genes for normalisation of gene expression during myofibroblast differentiation. TGFb2 induced Block, Southampton mRNA expression for all five smooth muscle related transcripts; aSMA, HCM and CPN 1 protein were also General Hospital, Southampton SO16 6YD, increased but desmin protein was not detectable. Although there was no difference in basal expression, UK; [email protected] HCM, CPN 1 and desmin were induced to a significantly greater extent in asthmatic fibroblasts than in those from normal controls (p = 0.041 and 0.011, respectively).
    [Show full text]
  • Interaction of Stellate Cells with Pancreatic Carcinoma Cells
    Cancers 2010, 2, 1661-1682; doi:10.3390/cancers2031661 OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Review Interaction of Stellate Cells with Pancreatic Carcinoma Cells Hansjörg Habisch 1, Shaoxia Zhou 1, Marco Siech 2 and Max G. Bachem 1,* 1 Department Clinical Chemistry and Central Laboratory, University of Ulm, Germany; E-Mails: [email protected] (H.H); [email protected] (S.Z.) 2 Department of surgery, Ostalbklinikum Aalen, Germany; E-Mail: [email protected] (M.S.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +49-731-500-67500/01; Fax: +49-731-500-67506. Received: 28 July 2010; in revised form: 2 September 2010 / Accepted: 2 September 2010 / Published: 9 September 2010 Abstract: Pancreatic cancer is characterized by its late detection, aggressive growth, intense infiltration into adjacent tissue, early metastasis, resistance to chemo- and radiotherapy and a strong ―desmoplastic reaction‖. The dense stroma surrounding carcinoma cells is composed of fibroblasts, activated stellate cells (myofibroblast-like cells), various inflammatory cells, proliferating vascular structures, collagens and fibronectin. In particular the cellular components of the stroma produce the tumor microenvironment, which plays a critical role in tumor growth, invasion, spreading, metastasis, angiogenesis, inhibition of anoikis, and chemoresistance. Fibroblasts, myofibroblasts and activated stellate cells produce the extracellular matrix components and are thought to interact actively with tumor cells, thereby promoting cancer progression. In this review, we discuss our current understanding of the role of pancreatic stellate cells (PSC) in the desmoplastic response of pancreas cancer and the effects of PSC on tumor progression, metastasis and drug resistance.
    [Show full text]
  • The Myofibroblast in Wound Healing and Fibrosis
    F1000Research 2016, 5(F1000 Faculty Rev):752 Last updated: 17 JUL 2019 REVIEW The myofibroblast in wound healing and fibrosis: answered and unanswered questions [version 1; peer review: 2 approved] Marie-Luce Bochaton-Piallat1, Giulio Gabbiani1, Boris Hinz2 1Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland 2Laboratory of Tissue Repair and Regeneration, Matrix Dynamics Group, Faculty of Dentistry, University of Toronto, Toronto, Canada First published: 26 Apr 2016, 5(F1000 Faculty Rev):752 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.8190.1) Latest published: 26 Apr 2016, 5(F1000 Faculty Rev):752 ( https://doi.org/10.12688/f1000research.8190.1) Reviewer Status Abstract Invited Reviewers The discovery of the myofibroblast has allowed definition of the cell 1 2 responsible for wound contraction and for the development of fibrotic changes. This review summarizes the main features of the myofibroblast version 1 and the mechanisms of myofibroblast generation. Myofibroblasts originate published from a variety of cells according to the organ and the type of lesion. The 26 Apr 2016 mechanisms of myofibroblast contraction, which appear clearly different to those of smooth muscle cell contraction, are described. Finally, we summarize the possible strategies in order to reduce myofibroblast F1000 Faculty Reviews are written by members of activities and thus influence several pathologies, such as hypertrophic the prestigious F1000 Faculty. They are scars and organ fibrosis. commissioned and are peer reviewed before Keywords publication to ensure that the final, published version Myofibroblast , mechanotransduction , myofibroblast generation , is comprehensive and accessible. The reviewers myofibroblast contraction , hypertrophic scars , organ fibroses who approved the final version are listed with their names and affiliations.
    [Show full text]
  • Fascial Anatomy in Manual Therapy: Introducing a New Biomechanical Julie Ann Day, PT Model
    Fascial Anatomy in Manual Therapy: Introducing a New Biomechanical Julie Ann Day, PT Model Centro Socio Sanitario dei Colli, Physiotherapy, Padova, Italy ABSTRACT detailed studies pertaining to specific areas suggested.17 Deep fascia is a well-vascular- Background and Purpose: Fascial of fascia are important, they do not pro- ized tissue often employed for plastic sur- anatomy studies are influencing our under- vide a vision of the human fascial system as gery flaps,18 and it responds to mechanical standing of musculoskeletal dysfunctions. an interrelated, tensional network of con- traction induced by muscular activity in dif- However, evidenced-based models for nective tissue. A few authors consider its ferent regions.19 It has an ectoskeletal role manual therapists working with move- 3-dimensional (3D) continuity8-10 but these and can potentially store mechanical energy ment dysfunction and pain are still devel- holistic models do not always provide spe- and distribute it in a uniform manner for oping. This review presents a synthesis of cific indications for treatment. A functional harmonious movement. The mechanical one biomechanical model and discusses model for the entire human fascial system properties of the fascial extracellular matrix underlying hypotheses in reference to some that correlates dysfunctional movement itself can be altered by external mechanical current trends in musculoskeletal research. and pain is in its infancy with regards to stimuli that stimulate protein turnover and Method: The author conducted principally evidence-based investigations and studies. fibroblastic activity.20,21 These characteris- a search of the health sciences literature This paper will examine a 3D bio- tics and the reported abundant innervation available on PubMed for the years 1995 to mechanical model for the human fascial of deep fascia indicate that it could have 2011, and consulted published texts con- system that takes into account movement the capacity to perceive mechanosensitive cerning this model.
    [Show full text]
  • Mysterious Myofibroblast: a Cell with Diverse Origin and Multiple Function
    Journal of Interdisciplinary Histopathology www.scopmed.org Review Article DOI: 10.5455/jihp.20160622013430 Mysterious myofibroblast: A cell with diverse origin and multiple function Sowmya Rao1, P. P. Jagadish Rao2, B. M. Jyothi3, V. K. Varsha4 1Department of Oral Pathology, Srinivas ABSTRACT Institute of Dental Myofibroblasts are one of the most controversial cells in recent times. Ever since its first discovery, numerous Sciences, Mangalore, Karnataka, India, discussions have been done on its illusive nature and functions. They are commonly considered as smooth 2Department of Forensic muscle like fibroblasts. Their presence and distribution in normal and pathological conditions are still not clear Medicine and Toxicology, since they are difficult to identify with the routine histological techniques. Recent studies have shown their Kasturba Medical ubiquitous presence in the body tissues hence suggesting their important role in both physiological functioning College, Mangalore, and pathological conditions. This review discusses briefly the cell in terms of its definition, possible precursors; Karnataka, India, mechanism involved in its modulation, most importantly how to differentiate it from its nearest counterparts 3Dental Assistant, 18, such as fibroblasts and smooth muscle cells and finally its fundamental role in physiology and pathology. Nautilus Court, Patterson Lakes, Victoria-3197, Australia, 4Department of Oral Pathology, Raja Rajeshwari Dental College and Hospital, Bengaluru, Karnataka, India Address for correspondence: Sowmya
    [Show full text]